Journal
NEUROLOGY AND CLINICAL NEUROSCIENCE
Volume 7, Issue 6, Pages 344-346Publisher
WILEY
DOI: 10.1111/ncn3.12325
Keywords
biomarkers; lactate; L-arginine; MELAS; pyruvate
Categories
Ask authors/readers for more resources
FGF21 and GDF15 are known as useful biomarkers for diagnosis of mitochondrial disorders, though their efficacy for evaluating disease severity is not well established. We determined their levels in a patient with a mitochondrial disorder and report our findings. Both biomarkers were elevated at the initial disease stage and then greatly increased with progression. Furthermore, those levels decreased along with improved clinical symptoms in response to pyruvate therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available